4/A//SEC Filing
Celator Pharmaceuticals Inc 4/A
Accession 0001144204-15-013066
CIK 0001327467operating
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 9:22 AM ET
Size
8.4 KB
Accession
0001144204-15-013066
Insider Transaction Report
Form 4/AAmended
Mayer Lawrence David
President and Head of Research
Transactions
- Award
Common Stock
2015-02-25+6,133→ 16,594 total - Award
Stock Option, Right to Buy
2015-02-25+80,000→ 80,000 totalExercise: $2.79Exp: 2025-02-25→ Common Stock (80,000 underlying)
Holdings
- 7,468(indirect: By Spouse)
Common Stock
- 3,631(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The options vest as follows: (i) 20,000 options vest on February 25, 2016; and (ii) 12 consecutive quarterly installments of 5,000 options vest on the 25th day of each May, August, November and February, beginning May 125, 2016 and continuing through February 25, 2019.
Documents
Issuer
Celator Pharmaceuticals Inc
CIK 0001327467
Entity typeoperating
Related Parties
1- filerCIK 0001327467
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 9:22 AM ET
- Size
- 8.4 KB